Quantcast

Latest Statin Stories

2014-08-11 23:05:39

A new study on statin drugs as a way to prevent or treat mesothelioma has yielded some disappointing results. Raleigh, NC (PRWEB) August 11, 2014 Researchers at the University of Western Australia say statin drugs used to treat high cholesterol are not likely to be of any help against pleural mesothelioma, despite their anti-cancer properties. Click here to read the full story just posted on the Surviving Mesothelioma website. New data collected by researchers with Australia’s National...

2014-08-05 17:03:42

American College of Cardiology The polypill, a combination pill taken just once a day that includes key medications for secondary prevention of heart disease, may be an effective low-cost strategy to improve adherence to medication recommendations and reduce costs, according to researchers from Spain and New York, who reviewed research on the polypill. The review article, A Polypill Strategy to Improve Global Secondary Cardiovascular Prevention, was published online today in the...

2014-07-30 08:33:01

Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo...

2014-07-30 08:32:55

- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor - PARIS and TARRYTOWN, N.Y., July 30, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to...

2014-07-30 08:32:08

Anticipate Topline Data in 6-8 months IRVINE, Calif., July 30, 2014 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001. This Phase 1b trial will be a continuation of the AHRO-001...

2014-07-21 12:24:55

Agents That Reduce the Incidence of Cardiovascular Adverse Events Remain a Key Unmet Need for Both Physicians and Payers, According to Findings from Decision Resources Group BURLINGTON, Mass., July 21, 2014 /PRNewswire/ -- Decision Resources Group finds that Amgen's evolocumab (AMG-145) is set to become the clinical gold-standard among statin add-on therapies used to treat patients with dyslipidemia. The competitive advantages this proprotein convertase subtilisin/kexin type 9 (PCSK9)...

2014-07-20 23:01:46

The Firm is actively investigating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. (PRWEB) July 20, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) alleging similar injuries caused by the cholesterol-lowering statin are being filed by the dozens in a federal multidistrict litigation underway in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According to...

2014-07-07 08:27:28

VISTA, Calif. and HARTFORD, Conn., July 7, 2014 /PRNewswire/ -- AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity...

2014-07-01 16:29:45

NY Times Article Brings Attention to Dangerous Lifestyle Related Epidemic and Suggests Critical Need for Therapy DENVER, July 1, 2014 /PRNewswire/ -- A recent New York Times article ("Threat Grows from Liver Illness Tied to Obesity", June 13 2014) alerting millions to the growing prevalence and seriousness of fatty liver disease revealed a stark and very concerning reality about therapeutic options. There are currently no drugs approved for either NAFLD (nonalcoholic fatty liver...

2014-06-23 23:05:46

Process for Filing Multidistrict Litigation Cases to be Streamlined as a Result ST. LOUIS, MO (PRWEB) June 23, 2014 The national law firm of Baron and Budd reports that the federal judge presiding over lawsuits involving the cholesterol drug Lipitor issued a Case Management Order on June 2, 2014. As a result, the process of filing new cases in the multidistrict litigation (MDL) will be streamlined. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502) In issuing the order, U.S. District...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related